AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 199 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $219,000 | -69.7% | 2,838 | -66.9% | 0.09% | -56.0% |
| Q2 2018 | $723,000 | +10.7% | 8,586 | +7.6% | 0.21% | +19.4% |
| Q1 2018 | $653,000 | +37.5% | 7,979 | -3.9% | 0.18% | +0.6% |
| Q4 2017 | $475,000 | -11.4% | 8,304 | +3.5% | 0.17% | +1.8% |
| Q3 2017 | $536,000 | +24.7% | 8,023 | -4.0% | 0.17% | +36.8% |
| Q2 2017 | $430,000 | +16.8% | 8,360 | +32.7% | 0.12% | -6.7% |
| Q1 2017 | $368,000 | – | 6,302 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |